Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 27;23(1):44-51.
doi: 10.1370/afm.3190.

Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices

Tristen L Hall  1 , David Mendez  2 , Chelsea Sobczak  3 , Susan Mathieu  3 , Kimberly Wiggins  3 , Kathy Cebuhar  3 , Lauren Quintana  3 , Jacob Weiss  3 , Kyle Knierim  3
Affiliations

Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices

Tristen L Hall et al. Ann Fam Med. .

Abstract

Purpose: Offering medication for opioid use disorder (MOUD) in primary care can increase access to effective opioid use disorder treatment and help address the US opioid crisis. We describe a primary care office-based opioid treatment program and addiction consultation service model designed to support small, rural clinics to increase their capacity for MOUD.

Methods: This is an evaluation of an intervention to increase clinic capacity to offer MOUD. The intervention consists of a standardized curriculum, addiction medicine consultants, practice facilitation, and financial incentives. Fifteen Colorado primary care practices participated from January 2022 through January 2023. Primary outcomes included overall change in the number of active buprenorphine prescriptions and implementation of MOUD milestones before and after the intervention.

Results: The mean number of active buprenorphine prescriptions in the 3 months preceding the intervention (baseline) increased from 2.1 (SD = 7.7) to 11.3 (SD = 11.2) at 13 months. Adjusted means from the Poisson model demonstrated significant improvement over time (P <.001). Mean implementation of MOUD milestones ranged from 23% to 40% at baseline and grew to 84% to 93% by the end of the program (P <.001).

Conclusions: This model supported primary care practices that were initially doing little to no MOUD prescribing, to prescribe at significantly higher levels by the end of the program. This scalable model for addiction consultation in primary care settings illustrates how education and support to clinical teams can help practices makes changes, especially those with limited MOUD experience.

Keywords: buprenorphine; opioid-related disorders; primary health care; program evaluation; substance-related disorders.

PubMed Disclaimer

References

    1. Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL.. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202-207. doi: 10.15585/mmwr.mm7006a4 - DOI - PMC - PubMed
    1. Saloner B, Karthikeyan S.. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013. JAMA. 2015;314(14):1515-1517. doi: 10.1001/jama.2015.10345 - DOI - PubMed
    1. Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M.. Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi: 10.1016/j.drugpo.2022.103786 - DOI - PMC - PubMed
    1. Gold SCY, Furniss A, Shah P, et al. . Closing the treatment gap for opioid use disorder in Colorado. Published 2021. Accessed Aug 7, 2024. https://medschool.cuanschutz.edu/farleyhealthpolicycenter/our-work/proje...
    1. Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB.. National trends in buprenorphine prescribing before and during the COVID-19 pandemic. J Subst Abuse Treat. 2023;144:108923. doi: 10.1016/j.jsat.2022.108923 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources